AbL Diagnostics (France) Market Value

ABLD Stock   2.40  0.10  4.00%   
AbL Diagnostics' market value is the price at which a share of AbL Diagnostics trades on a public exchange. It measures the collective expectations of AbL Diagnostics SA investors about its performance. AbL Diagnostics is trading at 2.40 as of the 26th of December 2024, a 4% down since the beginning of the trading day. The stock's open price was 2.5.
With this module, you can estimate the performance of a buy and hold strategy of AbL Diagnostics SA and determine expected loss or profit from investing in AbL Diagnostics over a given investment horizon. Check out AbL Diagnostics Correlation, AbL Diagnostics Volatility and AbL Diagnostics Alpha and Beta module to complement your research on AbL Diagnostics.
Symbol

Please note, there is a significant difference between AbL Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AbL Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbL Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AbL Diagnostics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AbL Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AbL Diagnostics.
0.00
10/27/2024
No Change 0.00  0.0 
In 2 months and 2 days
12/26/2024
0.00
If you would invest  0.00  in AbL Diagnostics on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding AbL Diagnostics SA or generate 0.0% return on investment in AbL Diagnostics over 60 days. AbL Diagnostics is related to or competes with Getlink SE, Compagnie, Compagnie, Amoeba SA, Vallourec, Alstom SA, and ABC Arbitrage. More

AbL Diagnostics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AbL Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AbL Diagnostics SA upside and downside potential and time the market with a certain degree of confidence.

AbL Diagnostics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for AbL Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AbL Diagnostics' standard deviation. In reality, there are many statistical measures that can use AbL Diagnostics historical prices to predict the future AbL Diagnostics' volatility.
Hype
Prediction
LowEstimatedHigh
0.982.403.82
Details
Intrinsic
Valuation
LowRealHigh
1.102.523.94
Details

AbL Diagnostics SA Backtested Returns

AbL Diagnostics SA secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had a -0.2% return per unit of return volatility over the last 3 months. AbL Diagnostics SA exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AbL Diagnostics' Risk Adjusted Performance of (0.12), coefficient of variation of (664.46), and Mean Deviation of 0.5994 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.15, which signifies not very significant fluctuations relative to the market. As returns on the market increase, AbL Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding AbL Diagnostics is expected to be smaller as well. At this point, AbL Diagnostics SA has a negative expected return of -0.28%. Please make sure to confirm AbL Diagnostics' jensen alpha, treynor ratio, and the relationship between the information ratio and total risk alpha , to decide if AbL Diagnostics SA performance from the past will be repeated at future time.

Auto-correlation

    
  -0.29  

Weak reverse predictability

AbL Diagnostics SA has weak reverse predictability. Overlapping area represents the amount of predictability between AbL Diagnostics time series from 27th of October 2024 to 26th of November 2024 and 26th of November 2024 to 26th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AbL Diagnostics SA price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current AbL Diagnostics price fluctuation can be explain by its past prices.
Correlation Coefficient-0.29
Spearman Rank Test-0.22
Residual Average0.0
Price Variance0.03

AbL Diagnostics SA lagged returns against current returns

Autocorrelation, which is AbL Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AbL Diagnostics' stock expected returns. We can calculate the autocorrelation of AbL Diagnostics returns to help us make a trade decision. For example, suppose you find that AbL Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

AbL Diagnostics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AbL Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AbL Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AbL Diagnostics stock over time.
   Current vs Lagged Prices   
       Timeline  

AbL Diagnostics Lagged Returns

When evaluating AbL Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AbL Diagnostics stock have on its future price. AbL Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AbL Diagnostics autocorrelation shows the relationship between AbL Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in AbL Diagnostics SA.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in AbL Stock

AbL Diagnostics financial ratios help investors to determine whether AbL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbL with respect to the benefits of owning AbL Diagnostics security.